Researchers report Alzheimer's disease and other neurodegenerative disorders can be confirmed in living patients by specific biomarkers in cerebrospinal fluid.
People diagnosed with Alzheimer's or mild cognitive impairment had weaker gamma wave activation in their brains than their peers without the neurodegenerative disorders.
Lower serum levels of the sugar metabolite GlcNAc was associated with progressive disability and neurodegeneration in patients with multiple sclerosis.
Cells that drive myelin repair become less efficient due to aging. Myelin loss results in cognitive decline and is central to a number of neurodegenerative diseases.
Genetically engineering botulinum toxin could help advance new treatments for everything from neurodegenerative disorders to cytokine storms.
Older women tended to have poorer memory fluidity scores than men of the same age group. However, the reverse was true for younger women. Researchers propose the difference could be a result of younger women having more access to higher education than previous generations.
Using over a century of data from other pandemics, and applying knowledge about the current COVID-19 infection, researchers predict the long term effects coronavirus will have on the brain and nervous system.
Rhizolutin, a bacterium found in the soil close to the roots of ginseng plants, appears to significantly dissociate the protein aggregates associated with Alzheimer's disease.
Neurons can counteract degeneration and promote survival by adapting their metabolism.
Two new studies from USC reveal the implications of air pollution on brain development and neurological health in children and older women.
Restoring HDAC1 could have potential benefits for those suffering from Alzheimer's disease and people with age-related cognitive decline.
Activating group 2 innate lymphoid cells in aging brains helps improve memory in mice. The findings could help in the development of treatments for neurodegenerative diseases associated with aging.
